What was the financial performance of Intuitive Surgical in 2003?

In 2003, Intuitive Surgical reported total sales of $91.7 million, an increase of 27% from $72.0 million in 2002. The company experienced a net loss of $9.6 million, an improvement from a net loss of $18.4 million in the prior year. This improvement was achieved despite significant restructuring and impairment charges related to the acquisition of Computer Motion.

What are the key strategic developments for Intuitive Surgical in 2003?

The most significant development was the acquisition of Computer Motion, Inc. for $148.5 million, which aimed to consolidate market position, acquire intellectual property, and achieve substantial cost synergies. The company also launched the fourth surgical arm upgrade for its da Vinci Surgical System and successfully completed a follow-on stock offering, raising $77.7 million in net proceeds, which bolstered its cash reserves.

How did the Computer Motion acquisition impact the company's financials?

The acquisition led to significant restructuring charges and impairment charges totaling approximately $6.3 million in 2003. These costs were incurred as part of integrating operations, eliminating redundancies, and writing down certain acquired assets. However, the company also reported that it achieved $28 million in annual pre-tax cost savings, exceeding its initial goal.

What is the outlook for Intuitive Surgical's revenue streams?

The company expects continued growth in revenue from its da Vinci Surgical Systems. Notably, revenue from instruments, accessories, and services is growing at a faster pace, representing 33% of total sales in 2003, up from 22% in 2002. This increasing contribution from recurring revenue streams is viewed positively as it leverages the installed base of da Vinci systems.

ISRG 10-K FY2003 Annual Report — Revenue, Net Income, EPS

Summary

Intuitive Surgical, Inc. (ISRG) filed its 2003 10-K report on March 11, 2004, detailing a transformative year characterized by the significant acquisition of Computer Motion, Inc. and continued growth in its da Vinci Surgical System sales. The company reported increased total sales of $91.7 million, up from $72.0 million in 2002, driven by both product and service revenue. Despite this top-line growth, ISRG reported a net loss of $9.6 million for the year, an improvement from a $18.4 million loss in 2002. This loss is attributed to substantial operating costs, including significant restructuring charges and impairment charges related to the Computer Motion acquisition, which aimed to consolidate operations and achieve substantial cost savings. Key strategic initiatives in 2003 included the launch of a fourth surgical arm upgrade for the da Vinci system and a successful follow-on stock offering that provided $77.7 million in net proceeds, bolstering the company's cash position to $112.9 million. The company is focused on establishing its "Intuitive Surgery" as the standard for complex procedures and is investing in R&D to enhance its technology and expand its product portfolio. Despite the net loss, the increasing proportion of revenue from instruments and services, alongside strategic acquisitions and product enhancements, indicates a positive trajectory for future revenue growth and operational efficiency.

Key Highlights

1Total sales increased by 27% to $91.7 million in 2003, driven by both product and service revenue growth.

2The company acquired Computer Motion, Inc. for $148.5 million, aiming for significant cost synergies and eliminating patent litigation.

3Net loss improved to $9.6 million in 2003 from $18.4 million in 2002, despite substantial restructuring and impairment charges.

4A successful follow-on stock offering in Q4 2003 raised $77.7 million in net proceeds, strengthening the company's liquidity to $112.9 million in cash and investments.

5Revenue from instruments and accessories, along with service and training, grew significantly, representing 33% of total sales in 2003, up from 22% in 2002.

6The company launched the fourth surgical arm upgrade for the da Vinci Surgical System, selling 37 units in 2003.

7Despite net losses, R&D expenses remained significant at $16.2 million, underscoring the commitment to technological advancement.

INTUITIVE SURGICAL INC Annual Report, Year Ended Dec 31, 2003

Summary

Key Highlights

Frequently Asked Questions